?
Combination therapies**: What other targets should be combined with LRRK2 inhibition?
active
open question
Created: 2026-04-25T20:29:28
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-c5daf63d-16fa-4c4f-bc87-7e
Open Question
open
Wiki: entities-lrrk2
Combination therapies**: What other targets should be combined with LRRK2 inhibition?
Importance Elo
1500
Field Rank
Rank #60 in entities
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page entities-lrrk2
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
Lysosomal Calcium Channel Modulation Therapy
candidate answer · hypothesis · 65%
Transglutaminase-2 Cross-Linking Inhibition Strategy
candidate answer · hypothesis · 65%
PARP1 Inhibition Therapy
candidate answer · hypothesis · 60%
TREM2-Mediated Selective Aggregate Clearance Pathway
candidate answer · hypothesis · 55%
R-Loop Resolution Enhancement Therapy
candidate answer · hypothesis · 55%
Low Complexity Domain Cross-Linking Inhibition
candidate answer · hypothesis · 50%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
Transglutaminase-2 Cross-Linking Inhibition Strategy
hypothesis | candidate_answer
TREM2-Mediated Selective Aggregate Clearance Pathway
hypothesis | candidate_answer
R-Loop Resolution Enhancement Therapy
hypothesis | candidate_answer
PARP1 Inhibition Therapy
hypothesis | candidate_answer
Low Complexity Domain Cross-Linking Inhibition
hypothesis | candidate_answer
Lysosomal Calcium Channel Modulation Therapy
hypothesis | candidate_answer
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:28.689914'} |
| field_tag | entities |
| source_id | entities-lrrk2 |
| sub_field | lrrk2 |
| source_kind | wiki |
| question_hash | 3d9020b080320d7a36238f003ed3d2851fe6c787cf7bc589a35a29618bc23bb1 |
| question_text | Combination therapies**: What other targets should be combined with LRRK2 inhibition? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page entities-lrrk2 |
| evidence_xref_at | 2026-04-27T14:34:58.901394+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
7
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.